Benicar HCT Tablets — Class II drug recall D-1507-2014
Terminated recall by Daiichi Sankyo Pharma Development, reported 2014-08-06, distributed nationwide. Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines durin
| Recall number | D-1507-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Daiichi Sankyo Pharma Development, Edison, NJ, United States |
| Recall initiated | 2014-07-12 |
| Classified | 2014-07-31 |
| Reported by FDA | 2014-08-06 |
| Terminated | 2015-03-16 |
| Distributed | Nationwide (US) |
| Quantity | 86 bottles |
| Reason classes | temperature control |
| NDC | 65597-0106-30 |
| Lot numbers | 0002073 |
| Expiration dates | 2016-12-31 |
Product
Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-106-30
Reason for recall
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1507-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.